Last Price
1.05
Today's Change
+0.071 (7.21%)
Day's Change
0.988 - 1.13
Trading Volume
1,089,284
Overview
Market Cap
37 Million
Shares Outstanding
35 Million
Avg Volume
4,723,418
Avg Price (50 Days)
0.71
Avg Price (200 Days)
2.16
PE Ratio
-2.85
EPS
-0.37
Earnings Announcement
23-Oct-2024
Previous Close
0.98
Open
0.99
Day's Range
0.9883 - 1.13
Year Range
0.46 - 6.1
Trading Volume
1,090,104
Price Change Highlight
1 Day Change
7.16%
5 Day Change
33.53%
1 Month Change
44.72%
3 Month Change
4.46%
6 Month Change
-61.21%
Ytd Change
-80.24%
1 Year Change
-81.19%
3 Year Change
-85.59%
5 Year Change
-92.97%
10 Year Change
-97.30%
Max Change
-99.33%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
CEO Morning Brief
3
4
CEO Morning Brief
5
CEO Morning Brief
OpenAI Lets Anyone Use Its New Voice Assistant in Third-party Apps
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
